The Daily Dish (6/02/21)

Israeli Pharma Firm NeuroRx Completes SPAC Merger at $1.5B Valuation 

NeuroRx, an Israel based clinical small molecule pharmaceutical has announced the completion of a merger with Big Rock Partners Acquisition Corporation which is a SPAC.

The deal is estimated to be worth $1.5 billion valuation and will trade on NASDAQ as NRXP. 

The company’s two primary products are ZYESAMI, an application for COVID-19 related respiratory failure and NRX-101 which focuses on suicidal bipolar depression and PTSD.

The company announced that the funds from the SPAC will be used to continue the development of its drugs ZYESAMI and NRX-101. 

Wall Street SPAC Fees Plunge 

The fees US banks have earned from SPAC’s have plunged in the last two months, disrupting what has been a main profit generator on Wall street.

Investment Banks have made a measly $430 million from SPAC’s in April and May compared with $3 Billion in fees in January and February. 

April and May only saw 30 US SPAC IPO’s, which was much lower than 299 in the first quarter. As a result of the slowdown, SPAC fees now lag behind the rate which was seen in the second half of 2020.

Some bankers remain hopeful of a rebound in the market, particularly if the wider pullback in the technology sector valuation reverses. 

The Headlines



Share on twitter
Share on reddit
Share on facebook
Share on linkedin

Leave a Reply

Your email address will not be published. Required fields are marked *

Social Media

Most Popular

Get The Latest Updates

Subscribe To Our Weekly Newsletter

No spam, notifications only about new products, updates.


On Key

Related Posts

Short Sellers Give Up

Today we Cover $WALD, $HYZN, $DNA, and more… While De-SPACs may have seemed like easy targets for short-sellers a few months ago, the combination of

Crash and Burn

Today we cover $PSFE, $RIDE, $BKSY and more… As more De-SPACs report Q3, premium valuations and lofty projections catch up to some companies. In today’s

SPACs Outperform in Q3

Today we cover $SOFI, $PAYO, $UTAA, and more… As the earnings season kicks into full gear, SPACs are delivering better than expected earnings and continue

Will Circle change the banking world?

The Rundown – Your weekly SPAC Deep Dive (11/10/21) What’s up everyone, Despite several attempts at banning or severely restricting a decentralized economy, cryptocurrencies have